Zentalis Pharmaceuticals, Inc. (ZNTL) Net income 2019–2025
Zentalis Pharmaceuticals, Inc. (ZNTL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$137.1MFY2025 · since FY2019: -$45.7M → -$137.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$137.1M | +17.4% |
| FY2024 | -$165.9M | +43.3% |
| FY2023 | -$292.3M | -23.4% |
| FY2022 | -$236.8M | -49.2% |
| FY2021 | -$158.7M | -34.7% |
| FY2020 | -$117.8M | -158.1% |
| FY2019 | -$45.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice